31 May 18
The post that was quoted here has been removedThe fraud here, of course, was falsely inflating their revenue numbers by 3 orders of magnitude.
As for the science, it was not peer reviewed, it was not independently validated and, despite their claims of developing a device that could accomplish the task, it did not work in any practical way in the clinic. This lab had problems from the very beginning and their investors did not thoroughly inspect or seek validation for the invention. Seemingly, no patients were harmed.
I'm in no way defending the company, but if all their claims were indeed speculative, venture capitalists should know what they're getting into here given the above huge caveats. It was a good but invalidated idea. The trick to investment in biotech is that their valuation is essentially zero until they develop a marketable product, and then it skyrockets. Investors want in RIGHT before the jump, but R&D is expensive and time-consuming and there is no guarantee that it will work. Their greed (and yes, greed of the executives and boards of the companies) often outweighs practical considerations.
01 Jun 18
Originally posted by @wildgrassQuite. So, to hold this case against science is just as wilfully stupid as taking my games as evidence that chess is a casual, meaningless game.
The fraud here, of course, was falsely inflating their revenue numbers by 3 orders of magnitude.
As for the science, it was not peer reviewed, it was not independently validated and, despite their claims of developing a device that could accomplish the task, it did not work in any practical way in the clinic. This lab had problems from the very beginning and their investors did not thoroughly inspect or seek validation for the invention.